{"version":"1.0","provider_name":"biotechlerncenter","provider_url":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/","title":"7. Et maintenant?","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"N6VJKgygsg\"><a href=\"https:\/\/biotechlerncenter.interpharma.ch\/fr\/sujets\/immuno-oncologie\/7-et-maintenant\/\">7. Et maintenant?<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/biotechlerncenter.interpharma.ch\/fr\/sujets\/immuno-oncologie\/7-et-maintenant\/embed\/#?secret=N6VJKgygsg\" width=\"600\" height=\"338\" title=\"\u00ab\u00a07. Et maintenant?\u00a0\u00bb &#8212; biotechlerncenter\" data-secret=\"N6VJKgygsg\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/biotechlerncenter.interpharma.ch\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"En mai 2010, une leuc\u00e9mie lymphoblastique aigu\u00eb, forme rare et particuli\u00e8rement agressive de cancer du sang, est diagnostiqu\u00e9e chez Emily Whitehead, 5 ans. Les m\u00e9decins s\u2019efforcent de combattre la leuc\u00e9mie par une chimioth\u00e9rapie, les chances de gu\u00e9rison semblent bonnes. Mais apr\u00e8s l\u2019\u00e9chec de deux tentatives, Emily n\u2019a plus que de faibles chances de survie. Ses [&hellip;]"}